Get the Stockscreener App
1.62
2.99%
-0.05
After Hours:
1.63
0.010
+0.62%
Omniab Inc stock is traded at $1.62, with a volume of 216.97K.
It is down -2.99% in the last 24 hours and down -9.50% over the past month.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
See More
Previous Close:
$1.67
Open:
$1.69
24h Volume:
216.97K
Relative Volume:
0.55
Market Cap:
$234.55M
Revenue:
$18.67M
Net Income/Loss:
$-64.78M
P/E Ratio:
-2.8081
EPS:
-0.5769
Net Cash Flow:
$-37.02M
1W Performance:
-10.99%
1M Performance:
-9.50%
6M Performance:
+3.85%
1Y Performance:
-33.61%
1-Day Range:
$1.615
$1.725
1-Week Range:
$1.615
$1.86
52-Week Range:
$1.22
$2.4701
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.62 | 241.79M | 18.67M | -64.78M | -37.02M | -0.5769 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
Quarterly Risk: Can OmniAb Inc disrupt its industryTrade Risk Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Buybacks Report: How correlated is OmniAb Inc to the S P5002026 Volume & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Aug Wrap: Will OmniAb Inc Equity Warrant benefit from rising consumer demand2026 Rallies & Precise Buy Zone Identification - baoquankhu1.vn
WOODSTOCK CORP's OmniAb Inc(OABI) Holding History - GuruFocus
If You Invested $1,000 in OmniAb, Inc. (OABI) - Stock Titan
Buyback Watch: What dividend growth rate does OmniAb Inc offer2026 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn
OmniAb files to sell 21.25M shares of common stock for holders - MSN
History Review: What is OmniAb Incs market position2026 Market Mood & High Accuracy Trade Alerts - baoquankhu1.vn
Take Profit: Can TLRY stock double in the next yearMarket Activity Report & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Update Recap: Is OmniAb Inc stock undervalued right nowOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Aug Selloffs: Is OmniAb Inc Equity Warrant a stock for growth or value investorsWeekly Trend Summary & Stepwise Swing Trade Plans - baoquankhu1.vn
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year - AOL.com
Novanta Stock Has Underperformed This Past Year, but One Investor Just Made a $36 Million Bet on Shares - AOL.com
Tuniu (TOUR) Q4 2025 Earnings Call Transcript - AOL.com
OmniAb 2025 Growth: 107 Partners, 407 Programs, and New OmniUltra LaunchNews and Statistics - IndexBox
OmniAb (OABI) Q4 2025 Earnings Call Transcript - The Globe and Mail
Is OmniAb Inc benefiting from innovation trends2026 Market Sentiment & Community Consensus Stock Picks - baoquankhu1.vn
Earnings call transcript: OmniAb beats Q4 2025 EPS forecast, stock rises - Investing.com Nigeria
Urban One (UONE) Q4 2025 Earnings Call Transcript - AOL.com
Earnings Miss: Will OmniAb Inc Equity Warrant benefit from rising consumer demandEarnings Performance Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
OmniAb outlines $25M–$30M 2026 revenue guidance as partner pipeline accelerates with OmniUltra and xPloration launches - MSN
OmniAb Earnings Call Highlights Platform Growth, Cash Path - The Globe and Mail
Ideal Power (IPWR) Q4 2025 Earnings Transcript - AOL.com
Analysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Cresco Labs (OtherCRLBF) - The Globe and Mail
OmniAb : March 2026 Corporate Overview - marketscreener.com
Q1 Earnings Forecast for OmniAb Issued By HC Wainwright - MarketBeat
OmniAb, Inc. (OABI) reports Q4 loss, misses revenue estimates - MSN
OmniAb (NASDAQ:OABI) Upgraded to Hold at Wall Street Zen - MarketBeat
Craig-Hallum Reaffirms Their Buy Rating on OmniAb (OABI) - The Globe and Mail
Benchmark Maintains Buy on OmniAb, Inc. (OABI) March 2026 - Meyka
US Market Wrap: Is OmniAb Inc stock undervalued right now2025 Key Lessons & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Revenue Check: Does OmniAb Inc stock have upside surprise potential - baoquankhu1.vn
Benchmark reiterates Buy on OmniAb stock, keeps $4 target - Investing.com
Benchmark reiterates Buy on OmniAb stock, keeps $4 target By Investing.com - Investing.com UK
OmniAb, Inc. (NASDAQ:OABI) Q4 2025 Earnings Call Transcript - Insider Monkey
HC Wainwright Estimates OmniAb's Q2 Earnings (NASDAQ:OABI) - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Senseonics Holdings (SENS), OmniAb (OABI) - The Globe and Mail
Weekly Earnings: Will OmniAb Inc Equity Warrant benefit from rising consumer demand2025 Growth vs Value & Weekly Breakout Watchlists - baoquankhu1.vn
CorMedix (CRMD) Q4 2025 Earnings Call Transcript - AOL.com
OmniAb Q4 2025 slides: revenue dips but pipeline hits 407 programs - Investing.com Australia
Gaotu (GOTU) Q4 2025 Earnings Call Transcript - AOL.com
Stifel reiterates Buy rating on OmniAb stock, cites partner growth By Investing.com - Investing.com Australia
Stifel reiterates Buy rating on OmniAb stock, cites partner growth - Investing.com India
OmniAb, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OmniAb Q4 2025 slides: revenue dips but pipeline hits 407 programs By Investing.com - Investing.com South Africa
OmniAb Q4 2025 Earnings Call Transcript - MarketBeat
OmniAb Q4 Earnings Call Highlights - MarketBeat
OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates - Bitget
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - PharmiWeb.com
OmniAb Inc reports results for the quarter ended December 31Earnings Summary - TradingView
OmniAb Inc (NASDAQ:OABI) Reports Q4 and Full-Year 2025 Earnings Miss, Provides 2026 Outlook - ChartMill
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):